Analyzing a cohort of non-muscle-invasive stage Ta bladder cancers, Hurst et al. reported that 74% of female-derived tumors (compared to 42% of male-derived tumors) contained one or more KDM6A mutation [80]. This evidence concerns the gene KDM6A and urinary bladder cancer.